IP77-13: Molecular mechanism of resistance to enfortumab vedotin (EV) and Nectin-4-modified molecular classification for muscle-invasive bladder cancer (MIBC)

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Information

Other
Best Poster

Log in

See all the content and easy-to-use features by logging in or registering!